- Contractors
- Pathcision Medicine, Inc.
Pathcision Medicine, Inc.
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Pathcision Medicine has 1 federal contract of $100,000 or more active since October 2023, with $3K obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 1 since FY2024$299,981 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- National Institutes of Health$3K on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- CK6QRF2GLBT1Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Sbir Concept Award for a Novel Delivery Approach to Transform Metastatic Pancreatic Cancer Treatment and PreventionNational Institutes of Health · 75N91025C00018 | $299,981 | Feb 10, 2027in 2 months | MA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health1 contract | $299,981 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $299,981 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Massachusetts1 contract | $299,981 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like Pathcision Medicine's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy